Temporal trends in characteristics and outcome of intensive care unit patients with systemic lupus erythematosus in Taiwan: A national population-based study

Lupus

Volumn 22, Issue 6, 2013, Pages 644-652

  Shen, H N ^a,b   Yang, H H ^a   Lu, C L ^a,b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

intensive care; outcome; Systemic lupus erythematosus

Indexed keywords

HYPERTENSIVE FACTOR;

ADULT; ARTICLE; DISEASE DURATION; FEMALE; HEMODIALYSIS; HUMAN; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN; TREATMENT OUTCOME;

INTENSIVE CARE; OUTCOME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TAIWAN; TREATMENT OUTCOME;

EID: 84878137156     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313476356     Document Type: Article

References (44)

1. Palatinus A, Adams M. Thrombosis in systemic lupus erythematosus. Semin Thromb Hemost. 2009 ; 35: 621-629
2. Navarra SV, Leynes MS. Infections in systemic lupus erythematosus. Lupus. 2010 ; 19: 1419-1424
3. Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GR. Systemic lupus erythematosus. Lancet. 2001 ; 357: 1027-1032
4. Raj R, Murin S, Matthay RA, Wiedemann HP. Systemic lupus erythematosus in the intensive care unit. Crit Care Clin. 2002 ; 18: 781-803
5. Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010 ; 39: 257-268
6. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore). 2003 ; 82: 299-308
7. Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 2550-2557
8. Ansell SM, Bedhesi S, Ruff B, et al. Study of critically ill patients with systemic lupus erythematosus. Crit Care Med. 1996 ; 24: 981-984
9. Williams FM, Chinn S, Hughes GR, Leach RM. Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis. 2002 ; 61: 414-421
10. Alzeer AH, Al-Arfaj A, Basha SJ, et al. Outcome of patients with systemic lupus erythematosus in intensive care unit. Lupus. 2004 ; 13: 537-542
11. Hsu CL, Chen KY, Yeh PS, et al. Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: A retrospective study. Crit Care. 2005 ; 9: R177-183
12. Namendys-Silva SA, Baltazar-Torres JA, Rivero-Sigarroa E, et al. Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit. Lupus. 2009 ; 18: 1252-1258
13. Godeau B, Boudjadja A, Dhainaut JF, et al. Outcome of patients with systemic rheumatic disease admitted to medical intensive care units. Ann Rheum Dis. 1992 ; 51: 627†- 631
14. Godeau B, Mortier E, Roy PM, et al. Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: A prognostic study of 181 patients. J Rheumatol. 1997 ; 24: 1317-1323
15. Thong BY, Tai DY, Goh SK, Johan A. An audit of patients with rheumatic disease requiring medical intensive care. Ann Acad Med Singapore. 2001 ; 30: 254-259
16. Moreels M, Melot C, Leeman M. Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med. 2005 ; 31: 591-593
17. Camargo JF, Tobon GJ, Fonseca N, et al. Autoimmune rheumatic diseases in the intensive care unit: Experience from a tertiary referral hospital and review of the literature. Lupus. 2005 ; 14: 315-320
18. Cavallasca JA, Del Rosario Maliandi M, Sarquis S, et al. Outcome of patients with systemic rheumatic diseases admitted to a medical intensive care unit. J Clin Rheumatol. 2010 ; 16: 400-402
19. Ranzani OT, Battaini LC, Moraes CE, et al. Outcomes and organ dysfunctions of critically ill patients with systemic lupus erythematosus and other systemic rheumatic diseases. Braz J Med Biol Res. 2011 ; 44: 1184-1193
20. Lee J, Yim JJ, Yang SC, et al. Outcome of patients with connective tissue disease requiring intensive care for respiratory failure. Rheumatol Int 2012; 32: 3353-3358. DOI: 10.1007/s00296-011-2158-6.
21. National Health Insurance Research Database. http://nhird.nhri.org.tw/en/ index.htm. Accessed 28 January 2013.
22. Chiu CC, Huang CC, Chan WL, et al. Increased risk of ischemic stroke in patients with systemic lupus erythematosus: A nationwide population-based study. Intern Med. 2012 ; 51: 17-21
23. Chen HA, Wang JJ, Chou CT, et al. Predictors of longterm mortality in patients with and without systemic lupus erythematosus on maintenance dialysis: A comparative study. J Rheumatol. 2011 ; 38: 2390-2394
24. Lin YC, Liang SJ, Liu YH, et al. Tuberculosis as a risk factor for systemic lupus erythematosus: Results of a nationwide study in Taiwan. Rheumatol Int. 2012 ; 32: 1669-1673
25. Liang JA, Sun LM, Yeh JJ, et al. Malignancies associated with systemic lupus erythematosus in Taiwan: A nationwide population-based cohort study. Rheumatol Int. 2012 ; 32: 773-778
26. Chen YJ, Chang YT, Wang CB, Wu CY. Malignancy in systemic lupus erythematosus: A nationwide cohort study in Taiwan. Am J Med. 2010 ; 123: 1150.e1-1150.e6
27. Chiu YM, Lai CH. Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. Lupus. 2010 ; 19: 1250-1255
28. Wang TF, Lin HC. Relationship between caseload volume and outcome for systemic lupus erythematosus treatment: The experience of Taiwan. J Rheumatol. 2008 ; 35: 1795-1800
29. Huang JL, Yao TC, See LC. Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: A nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol. 2004 ; 22: 776-780
30. Shen HN, Lu CL, Yang HH. Epidemiologic trend of severe sepsis in Taiwan from 1997 through 2006. Chest. 2010 ; 138: 298-304
31. Shen HN, Lu CL. Incidence, resource use, and outcome of acute pancreatitis with/without intensive care: A nationwide population-based study in Taiwan. Pancreas. 2011 ; 40: 10-15
32. Shen HN, Lu CL, Yang HH. Increased risks of acute organ dysfunction and mortality in intensive care unit patients with schizophrenia: A nationwide population-based study. Psychosom Med. 2011 ; 73: 620-626
33. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987 ; 40: 373-383
34. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992 ; 45: 613-619
35. Hanley JA, Negassa A, Edwardes MD, Forrester JE. Statistical analysis of correlated data using generalized estimating equations: An orientation. Am J Epidemiol. 2003 ; 157: 364-375
36. Ward MM. Hospital experience and mortality in patients with systemic lupus erythematosus. Arthritis Rheum. 1999 ; 42: 891-898
37. Urowitz MB, Gladman DD, Tom BD, Ibanez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol. 2008 ; 35: 2152-2158
38. Lerang K, Gilboe IM, Gran JT. Differences between rheumatologists and other internists regarding diagnosis and treatment of systemic lupus erythematosus. Rheumatology (Oxford). 2012 ; 51: 663-669
39. Ruiz-Irastorza G, Khamashta MA. Hydroxychloroquine: The cornerstone of lupus therapy. Lupus. 2008 ; 17: 271-273
40. Lee SJ, Silverman E, Bargman JM. The role of antimalarial agents in the treatment of SLE and lupus nephritis. Nat Rev Nephrol. 2011 ; 7: 718-729
41. Vincent JL. Critical care nephrology: A multidisciplinary approach. Contrib Nephrol. 2007 ; 156: 24-31
42. Mok CC, Ho CT, Wong RW, Lau CS. Damage accrual in southern Chinese patients with systemic lupus erythematosus. J Rheumatol. 2003 ; 30: 1513-1519
43. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum. 1996 ; 39: 363-369
44. Jonsen A, Clarke AE, Joseph L, et al. Association of the Charlson comorbidity index with mortality in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011 ; 63: 1233-1237